A TRANSCRIPTION FACTOR SIGNATURE CAN IDENTIFY THE CMS4 SUBTYPE AND STRATIFY THE PROGNOSTIC RISK OF COLORECTAL CANCER

A Transcription Factor Signature Can Identify the CMS4 Subtype and Stratify the Prognostic Risk of Colorectal Cancer

BackgroundColorectal cancer (CRC) is a heterogeneous disease, and current classification systems are insufficient for stratifying patients with different risks.This study aims to develop a generalized, individualized prognostic consensus molecular subtype (CMS)-transcription factors (TFs)-based Play Mat signature that can predict the prognosis of C

read more

A Transcription Factor Signature Can Identify the CMS4 Subtype and Stratify the Prognostic Risk of Colorectal Cancer

BackgroundColorectal cancer (CRC) is a heterogeneous disease, and current classification systems are insufficient for stratifying patients with different risks.This study aims to develop a generalized, individualized prognostic consensus molecular subtype (CMS)-transcription factors (TFs)-based Play Mat signature that can predict the prognosis of C

read more